Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | NX-1607 |
Trade Name | |
Synonyms | NX1607|NX 1607 |
Drug Descriptions |
NX-1607 is a small molecule Cblb inhibitor, which potentially enhances antitumor immune response (J Clin Oncol 40, no. 16_suppl (June 01, 2022) TPS2691). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C185125 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
NX-1607 | NX-1607 | 0 | 1 |